Santeon, Utrecht, The Netherlands.
Department of Internal Medicine, Leiden University Medical Centre, Leiden, the Netherlands.
BMC Nephrol. 2023 Mar 22;24(1):66. doi: 10.1186/s12882-023-03115-3.
Guidelines on chronic kidney disease (CKD) recommend that nephrologists use clinical prediction models (CPMs). However, the actual use of CPMs seems limited in clinical practice. We conducted a national survey study to evaluate: 1) to what extent CPMs are used in Dutch CKD practice, 2) patients' and nephrologists' needs and preferences regarding predictions in CKD, and 3) determinants that may affect the adoption of CPMs in clinical practice.
We conducted semi-structured interviews with CKD patients to inform the development of two online surveys; one for CKD patients and one for nephrologists. Survey participants were recruited through the Dutch Kidney Patient Association and the Dutch Federation of Nephrology.
A total of 126 patients and 50 nephrologists responded to the surveys. Most patients (89%) reported they had discussed predictions with their nephrologists. They most frequently discussed predictions regarded CKD progression: when they were expected to need kidney replacement therapy (KRT) (n = 81), and how rapidly their kidney function was expected to decline (n = 68). Half of the nephrologists (52%) reported to use CPMs in clinical practice, in particular CPMs predicting the risk of cardiovascular disease. Almost all nephrologists (98%) reported discussing expected CKD trajectories with their patients; even those that did not use CPMs (42%). The majority of patients (61%) and nephrologists (84%) chose a CPM predicting when patients would need KRT in the future as the most important prediction. However, a small portion of patients indicated they did not want to be informed on predictions regarding CKD progression at all (10-15%). Nephrologists not using CPMs (42%) reported they did not know CPMs they could use or felt that they had insufficient knowledge regarding CPMs. According to the nephrologists, the most important determinants for the adoption of CPMs in clinical practice were: 1) understandability for patients, 2) integration as standard of care, 3) the clinical relevance.
Even though the majority of patients in Dutch CKD practice reported discussing predictions with their nephrologists, CPMs are infrequently used for this purpose. Both patients and nephrologists considered a CPM predicting CKD progression most important to discuss. Increasing awareness about existing CPMs that predict CKD progression may result in increased adoption in clinical practice. When using CPMs regarding CKD progression, nephrologists should ask whether patients want to hear predictions beforehand, since individual patients' preferences vary.
慢性肾脏病(CKD)指南建议肾病学家使用临床预测模型(CPM)。然而,CPM 在临床实践中的实际应用似乎受到限制。我们进行了一项全国性调查研究,以评估:1)CPM 在荷兰 CKD 实践中的应用程度,2)患者和肾病学家对 CKD 预测的需求和偏好,以及 3)可能影响 CPM 在临床实践中采用的决定因素。
我们对 CKD 患者进行了半结构化访谈,为两项在线调查的制定提供了信息;一项是针对 CKD 患者的,另一项是针对肾病学家的。通过荷兰肾脏患者协会和荷兰肾脏病学会招募调查参与者。
共有 126 名患者和 50 名肾病学家对调查做出了回应。大多数患者(89%)表示他们曾与肾病学家讨论过预测。他们最常讨论的预测涉及 CKD 进展:当他们预计需要肾脏替代治疗(KRT)时(n=81),以及他们的肾功能预计会多快下降时(n=68)。一半的肾病学家(52%)报告在临床实践中使用 CPM,特别是预测心血管疾病风险的 CPM。几乎所有的肾病学家(98%)都报告与患者讨论了预期的 CKD 轨迹;即使那些不使用 CPM 的肾病学家(42%)也是如此。大多数患者(61%)和肾病学家(84%)选择预测患者何时需要未来 KRT 的 CPM 作为最重要的预测。然而,一小部分患者表示他们根本不想了解关于 CKD 进展的预测(10-15%)。不使用 CPM 的肾病学家(42%)报告称,他们不知道可以使用哪些 CPM,或者认为自己对 CPM 的了解不足。根据肾病学家的说法,在临床实践中采用 CPM 的最重要决定因素是:1)对患者的可理解性,2)作为标准护理的整合,3)临床相关性。
尽管荷兰 CKD 实践中的大多数患者报告与他们的肾病学家讨论了预测,但很少将 CPM 用于此目的。患者和肾病学家都认为预测 CKD 进展的 CPM 最重要。提高对预测 CKD 进展的现有 CPM 的认识,可能会导致在临床实践中更广泛的采用。当使用 CPM 预测 CKD 进展时,肾病学家应该在使用之前询问患者是否希望听到预测,因为个体患者的偏好不同。